These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11862739)

  • 21. Role of individualization of hepatitis C virus (HCV) therapy duration in HIV/HCV-coinfected individuals.
    Hopkins S; Lambourne J; Farrell G; McCullagh L; Hennessy M; Clarke S; Mulcahy F; Bergin C
    HIV Med; 2006 May; 7(4):248-54. PubMed ID: 16630037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiological, clinical and therapeutical aspects of HIV/HCV coinfection in a series of HIV seropositive Umbrian patients].
    Francisci D; Valente M; Di Candilo F; Sfara C; Conte ME; Canovari B; Baldelli F; Stagni G
    Recenti Prog Med; 2004 Nov; 95(11):521-4. PubMed ID: 15598089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HCV infection in the setting of HIV: prevalence, disease, treatment.
    Laurence J
    AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952
    [No Abstract]   [Full Text] [Related]  

  • 24. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.
    Torti C; Barnes E; Quiros-Roldan E; Puoti M; Carosi G; Klenerman P
    Antivir Ther; 2004 Feb; 9(1):139-42. PubMed ID: 15040546
    [No Abstract]   [Full Text] [Related]  

  • 25. First things first: balancing hepatitis C and human immunodeficiency virus.
    Graham CS; Koziel MJ
    Clin Infect Dis; 2003 Feb; 36(3):368-9. PubMed ID: 12539080
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapy of hepatitis C in patients with HIV infection.
    Daugherty T; Bonacini M
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):375-84. PubMed ID: 15954854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007.
    Vellozzi C; Buchacz K; Baker R; Spradling PR; Richardson J; Moorman A; Tedaldi E; Durham M; Ward J; Brooks JT;
    J Viral Hepat; 2011 May; 18(5):316-24. PubMed ID: 20367803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy.
    Yacisin K; Maida I; Ríos MJ; Soriano V; Núñez M
    AIDS Res Hum Retroviruses; 2008 Jul; 24(7):935-40. PubMed ID: 18593347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients.
    Medrano J; Resino S; Vispo E; Madejón A; Labarga P; Tuma P; Martín-Carbonero L; Barreiro P; Rodriguez-Novoa S; Jiménez-Nacher I; Soriano V
    J Viral Hepat; 2011 May; 18(5):325-30. PubMed ID: 20456635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Coinfection of hepatitis C virus and human immunodeficiency virus and antiretroviral multitherapies].
    Zylberberg H; Pol S
    Gastroenterol Clin Biol; 1999; 23(8-9):878-81. PubMed ID: 10533139
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV-infected inpatients in the HAART era: how do hepatitis C virus coinfected patients differ?
    Falusi OM; Pulvirenti J; Sarazine J; Shastri P; Gail C; Glowacki R
    AIDS Patient Care STDS; 2003 Jan; 17(1):13-6. PubMed ID: 12614516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for managing hepatitis C virus infection in HIV-infected patients.
    Clanon KA
    Top HIV Med; 2003; 11(2):50-4. PubMed ID: 12717042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C co-infection review.
    Raymond D
    Posit Aware; 2004; 15(2):28-30, 33. PubMed ID: 15106528
    [No Abstract]   [Full Text] [Related]  

  • 34. Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Macías J; Pineda JA; Lozano F; Corzo JE; Ramos A; León E; García-García JA; Fernández-Rivera J; Mira JA; Gómez-Mateos J
    Eur J Clin Microbiol Infect Dis; 2003 Nov; 22(11):675-80. PubMed ID: 14574616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy.
    Chung RT; Kim AY; Polsky B
    Antivir Chem Chemother; 2001; 12 Suppl 1():73-91. PubMed ID: 11594692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV and hepatitis C virus co-infection.
    Sulkowski M
    Hopkins HIV Rep; 1998 Nov; 10(6):8, 12. PubMed ID: 11366132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges for hepatitis C patients coinfected with HIV.
    Bruno R; Cotler S; Sacchi P; Ciappina V; Rondanelli M; Filice G
    Am Clin Lab; 2002 Apr; 21(3):26-31. PubMed ID: 12038082
    [No Abstract]   [Full Text] [Related]  

  • 38. Current issues in hepatitis C, HIV co-infection discussed at lunch and learn.
    Monarch A
    Surviv News (Atlanta Ga); 2002 Sep; ():14. PubMed ID: 12765135
    [No Abstract]   [Full Text] [Related]  

  • 39. Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.
    Schulze Zur Wiesch J; Pieper D; Stahmer I; Eiermann T; Buggisch P; Lohse A; Hauber J; van Lunzen J
    Clin Infect Dis; 2009 Aug; 49(3):466-72. PubMed ID: 19580412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
    Núñez M; Soriano V
    J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.